Cytoplasmic body myopathy masquerading as motor neuron disease

Muscle and Nerve

Volumn 30, Issue 5, 2004, Pages 667-672

  Krishnan, Arun V ^a,b   Pamphlett, Roger ^c   Burke, David ^d   Wills, Edward J ^e   Kiernan, Matthew C ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

Cytoplasmic body; Desmin; Motor neuron disease; Myofibrillar myopathy, myopathy

Indexed keywords

RILUZOLE;

ADULT; ANAMNESIS; BLOOD EXAMINATION; CASE REPORT; CELL INCLUSION; CLINICAL FEATURE; CYTOPLASMIC BODY MYOPATHY; DYSPHAGIA; ELECTROMYOGRAPHY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MOTOR NERVE CONDUCTION; MOTOR NEURON DISEASE; MUSCLE BIOPSY; MUSCLE DENERVATION; MUSCLE WEAKNESS; MYOPATHY; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; REVIEW;

ACTION POTENTIALS; ADULT; CYTOPLASM; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INCLUSION BODIES; MOTOR NEURON DISEASE; MUSCLE FIBERS; MUSCULAR DISEASES;

EID: 7444237621     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20115     Document Type: Review

References (40)

1. Ariza A, Coll J, Fernandez-Figueras MT, Lopez MD, Mate JL, Garcia O, Fernandez-Vasalo A, Navas-Palacios JJ. Desmin myopathy: a multisystem disorder involving skeletal, cardiac, and smooth muscle. Hum Pathol 1995;26:1032-1037.
2. Baeta AM, Figarella-Branger D, Bille-Turc F, Lepidi H, Pellissier JF. Familial desmin myopathies and cytoplasmic body myopathies. Acta Neuropathol 1996;92:499-510.
3. Bischoff C, Stalberg E, Falck B, Eeg-Olofsson KE. Reference values of motor unit action potentials obtained with multi-MUAP analysis. Muscle Nerve 1994;17:842-851.
4. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical Limits of Amyotrophic Lateral Sclerosis' workshop contributors. J Neurol Sci 1994;124(suppl):S96-S107.
5. Capetanaki Y. Desmin cytoskeleton: a potential regulator of muscle mitochondrial behavior and function. Trends Cardiovasc Med 2002;12:339-348.
6. Caron A, Gohel C, Mollaret K, Morello R, Chapon F. Study of some components of the cytoskeleton in muscular disorders with nonspecific cytoplasmic bodies. Acta Neuropathol 1999; 97:267-274.
7. Dalakas MC, Park KY, Semino-Mora C, Lee HS, Sivakumar K, Goldfarb LG. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med 2000;342:770-780.
8. Edstrom L, Thornell LE, Albo J, Landin S, Samuelsson M. Myopathy with respiratory failure and typical myofibrillar lesions. J Neurol Sci 1990;96:211-228.
9. Engel W. The essentiality of histo- and cytochemical studies of skeletal muscle in the investigation of neuromuscular disease. Neurology 1962;12:778-794.
10. Gilgun-Sherki Y, Panet H, Melamed E, Offen D. Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis. Brain Res 2003;989:196-204.
11. Goebel HH, D'Agostino AN, Wilson J, Cole G, Foroud T, Koller D, Farlow M, Azzarelli B, Muller J. Spheroid body myopathy revisited. Muscle Nerve 1997;20:1127-1136.
12. Goebel HH, Muller J, Gillen HW, Merritt AD. Autosomal dominant 'spheroid body myopathy.' Muscle Nerve 1978;1: 14-26.
13. Gubbay SS, Kahana E, Zilber N, Cooper G, Pintov S, Leibowitz Y. Amyotrophic lateral sclerosis. A study of its presentation and prognosis. J Neurol 1985;232:295-300.
14. Haddad H, Cifuentes-Diaz C, Miroglio A, Roblot N, Joshi V, Melki J. Riluzole attenuates spinal muscular atrophy disease progression in a mouse model. Muscle Nerve 2003;28:432-437.
15. Helliwell TR, Green AR, Green A, Edwards RH. Hereditary distal myopathy with granulo-filamentous cytoplasmic inclusions containing desmin, dystrophin and vimentin. J Neurol Sci 1994;124:174-187.
16. Huntington Study Group. Dosage effects of riluzole in Huntington's disease: a multicenter placebo-controlled study. Neurology 2003;61:1551-1556.
17. Jankovic J, Hunter G. A double-blind, placebo-controlled and longitudinal study of riluzole in early Parkinson's disease. Parkinsonism Rel Disord 2002;8:271-276.
18. Jerusalem F, Ludin H, Bischoff A, Hartmann G. Cytoplasmic body neuromyopathy presenting as respiratory failure and weight loss. J Neurol Sci 1979;41:1-9.
19. Kalkers NF, Barkhof F, Bergers E, van Schijndel R, Polman CH. The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study. Mult Scler 2002;8:532-533.
20. Kiernan MC. Motor neuron disease: a Pandora's box. Med J Austral 2003;178:311-312.
21. Kiernan MC, Guglielmi JM, Kaji R, Murray NM, Bostock H. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain 2002;125: 664-675.
22. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 1996;347:1425-1431.
23. Milner DJ, Mavroidis M, Weisleder N, Capetanaki Y. Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function. J Cell Biol 2000;150:1283-1298.
24. Morris HR, Landon D, Morgan-Hughes J, Brown P. Late-onset cytoplasmic body myopathy resembling myotonic dystrophy. Muscle Nerve 1999;22:781-782.
25. Nakano S, Engel AG, Waclawik AJ, Emslie-Smith AM, Busis NA. Myofibrillar myopathy with abnormal foci of desmin positivity. 1, Light and electron microscopy analysis of 10 cases. J Neuropathol Exp Neurol 1996;55:549-562.
26. Nakashima N, Tamura Z, Okamoto S, Goto H. Inclusion bodies in human neuromuscular disorder. Arch Neurol 1970; 22:270-278.
27. Osborn M, Goebel HH. The cytoplasmic bodies in a congenital myopathy can be stained with antibodies to desmin, the muscle-specific intermediate filament protein. Acta Neuropathol 1983;62:149-152.
28. Patel H, Berry K, MacLeod P, Dunn HG. Cytoplasmic body myopathy. Report on a family and review of the literature. J Neurol Sci 1983;60:281-292.
29. Pezeshkpour G, Illa I, Dalakas MC. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine- associated myopathies. Hum Pathol 1991;22:1281-1288.
30. Reimann J, Kunz W, Vielhaber S, Kappes-Horn K. Schroder R. Mitochondrial dysfunction in myofibrillar myopathy. Neuropathol Appl Neurobiol 2003;29:45-51.
31. Ringel SP, Murphy JR, Alderson MK, Bryan W, England JD, Miller RG, Petajan JH, Smith SA, Roelofs RI, Ziter F, Lee MY, Brinkmann JD, Almada A, Gappmaier E, Graves J, Herbelin L, Mendoza M, Mylar D, Smith P, Yu P. The natural history of amyotrophic lateral sclerosis. Neurology 1993;43:1316-1322.
32. Rosas HD, Koroshetz WJ, Jenkins BG, Chen YI, Halden DL, Beal MF, Cudkowicz ME. Riluzole therapy in Huntington's disease (HD). Mov Disord 1999;14:326-330.
33. Russman BS, Iannaccone ST, Samaha FJ. A phase 1 trial of riluzole in spinal muscular atrophy. Arch Neurol 2003;60: 1601-1603.
34. Sabatelli M, Bertini E, Ricci E, Salviati G, Magi S, Papacci M, Tonali P. Peripheral neuropathy with giant axons and cardiomyopathy associated with desmin type intermediate filaments in skeletal muscle. J Neurol Sci 1992;109:1-10.
35. Sekijima Y, Ikeda S, Katai S, Matsuda M, Hashimoto T, Hamta S, Owa M, Sakai T, Takeda S, Yanagisawa N. Cytoplasmic body myopathy with hypertrophic cardiomyopathy. Intern Med 1995;34:166-170.
36. Selcen D, Ohno K, Engel A. Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients. Brain 2004; 127:439-451.
37. Seppi K, Mueller J, Bodner T, Brandauer E, Benke T, Weirich-Schwaiger H, Poewe W, Wenning GK. Riluzole in Huntington's disease: an open label study with one year follow up. J Neurol 2001;248:866-869.
38. Vajsar J, Balslev T, Ray PN, Siegel-Bartelt J, Jay V. Congenital cytoplasmic body myopathy with survival motor neuron gene deletion or Werdnig-Hoffmann disease. Neurology 1998;51: 873-875.
39. Wauschit J, Nakano S, Goudeau B, Strobel T, Rinner W, Wimmer G, Resch H, Jaksch M, Akiguchi I, Vicart P, Budka H. Myofibrillar (desmin-related) myopathy: clinico-pathological spectrum in 3 cases and review of the literature. Clin Neuropathol 2002;21:220-231.
40. Wolburg H, Schlote W, Langohr HD, Peiffer J, Reiher KH, Heckl RW. Slowly progressive congenital myopathy with cytoplasmic bodies - report of two cases and a review of the literature. Clin Neuropathol 1982;1:55-66.